Datlowe
Datlowe develops AI-powered clinical risk detection applications for hospitals, offering HAIDI for real-time infection surveillance and MERIE for pharmacotherapy monitoring, serving 55+ hospitals across Central and Eastern Europe from Prague.
- Company typePrivate
- Founded2017
- HeadquartersMalá Strana, Czechia
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Datlowe does
Datlowe is a privately held Prague-based company that builds AI-powered clinical risk detection applications for hospitals. Its product suite centers on a proprietary AI platform that continuously analyzes hospital data — including structured records (laboratory results, prescriptions, hospitalization data) and unstructured clinical notes — to surface risks earlier than traditional manual surveillance. The platform powers two flagship applications: HAIDI, which performs real-time hospital infection surveillance and detection of healthcare-associated infections, and MERIE, which performs real-time pharmacotherapy monitoring to flag medication risks and drug interactions for clinical pharmacists. Both applications are deployed on-premise within hospital IT environments, are SNOMED CT and FHIR compliant, and are positioned as GDPR-aligned with full data sovereignty for the hospital.
The company operates a subscription-based enterprise licensing model with annual or multi-year contracts priced per deployment scope, sold through a direct field-sales motion targeting hospital management, infection control teams, clinical pharmacists, and quality managers. Go-to-market is organized by region with dedicated sales and partnership coverage in the Czech Republic (Jan Somol, Head of Sales), Austria (Thomas Dewald, Senior Partnership Manager), and Poland (Sławomir Miazek, Partnership Manager). The customer base spans 55+ hospitals across Central and Eastern Europe — including Czech groups such as Penta Hospitals CZ, University Hospital Motol, and University Hospital Brno; Austrian hospitals within the Vinzenz Gruppe; and Slovakia's University Hospital Trnava — with reported analytics covering 45+ million hospitalizations and millions of pages of clinical documentation.
Founded in 2017, Datlowe operates with a lean team of 1–10 employees and has scaled to date without disclosed external venture funding. It supports its commercial motion through regional sales hires, multi-language digital presence (Czech, English, German, Polish), active conference participation across CEE, and earned media coverage in Forbes Czech and Czech Television. The CEO and co-founder is Jakub Kozák. Pricing is not publicly disclosed and contracts are negotiated enterprise-wide.
Datlowe firmographics
Firmographics- Name
- Datlowe
- Legal name
- Datlowe, s.r.o.
- Website
- https://datlowe.cz
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Datlowe develops AI-powered clinical risk detection applications for hospitals, offering HAIDI for real-time infection surveillance and MERIE for pharmacotherapy monitoring, serving 55+ hospitals across Central and Eastern Europe from Prague.
- Ownership category
- akta.pro rank
Datlowe industry classification
Industry- Product category
- Healthcare AI Analytics Software
- NAICS
- Computer Facilities Management Services (541513)
- SIC
- Services-Health Services (8000)
- akta.pro industry
- SaMD – Monitoring, Triage & Risk Stratification SoftwareHealthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) PlatformsHealthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
Keywords
Where Datlowe is headquartered
LocationHeadquarters
- HQ city
- Malá Strana
- HQ country
- Czechia
- HQ region
- Europe
Offices2 records
Markets served
Datlowe business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- AI Platform Subscription (HAIDI): Subscription-based licensing of HAIDI infection monitoring application deployed on-premise at hospitals. Annual or multi-year contracts with pricing based on hospital size or deployment scope.
- AI Platform Subscription (MERIE): Subscription-based licensing of MERIE pharmacotherapy monitoring application deployed on-premise at hospitals. Annual or multi-year contracts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise hospital subscription - pricing based on deployment scope |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Datlowe product offering
Product offeringCore offering
Datlowe develops and sells an AI-powered healthcare data analytics platform deployed on-premise inside hospitals. Its two flagship applications, HAIDI for real-time hospital infection surveillance and MERIE for real-time pharmacotherapy monitoring, continuously analyze clinical data (clinical notes, lab results, prescriptions, patient records) to detect risks earlier than traditional manual surveillance methods and generate actionable alerts for healthcare professionals.
Product overview
Datlowe offers an AI platform with two core clinical applications: HAIDI for real-time hospital infection surveillance and MERIE for real-time pharmacotherapy monitoring. The platform continuously analyzes hospital data (clinical notes, lab results, prescriptions, patient records) to detect risks early and generate actionable alerts for healthcare professionals. Both applications share the same underlying Datlowe AI platform infrastructure and are deployed on-premise within hospital IT environments.
Differentiator
Problem solved
Functional benefit
Brands
- Datlowe AI platform: The core AI platform that continuously analyses hospital data and powers the company's applications HAIDI and MERIE.
- HAIDI
- MERIE
Products and services
- Datlowe AI Platform
Quantifiable outcome
- 90% reduction in manual data review time
- +4 more outcomes
Companies that use Datlowe
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles1 record
Datlowe technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
Datlowe partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- Penta HospitalscorePenta Hospitals is a major healthcare provider group in Czech Republic using HAIDI for automated infection surveillance. Multiple facilities including hospitals in Jihlava, Havířov, and České Budějovice are shown as customer logos.
- University Hospital Trnava (FN Trnava)coreUniversity Hospital Trnava in Slovakia is a key customer using HAIDI for infection control. Case study featured with Jaroslava Sokolová, Head of Department of Hospital Hygiene and Epidemiology.
- University Hospital Motol (FN Motol)coreFN Motol, one of the largest hospitals in Czech Republic, is listed as a customer using Datlowe solutions.
- Vinzenz GruppecoreAustrian hospital group (Vinzenz Gruppe) including Gottlicher Heiland Krankenhaus Wien and Herz Jesu Krankenhaus Wien using Datlowe solutions.
- Hospital of Merciful Sisters RiedcoreAustrian hospital (Barmherzige Schwestern Krankenhaus Ried) using HAIDI for real-time infection surveillance. Case study featured with Dr. Milo Halabi.
- Orthopädisches Spital SpeisingcoreAustrian orthopedic hospital in Vienna's Vinzenz Gruppe using Datlowe solutions.
- Regional Hospital Liberec (Krajská nemocnice Liberec)coreRegional hospital in Liberec, Czech Republic, listed as customer of Datlowe solutions.
- University Hospital Brno (FN Brno)coreMajor teaching hospital and university medical center in Brno, Czech Republic, using Datlowe solutions.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Datlowe competitors and assessment
Company assessmentDirect peers
- LeanTaas: AI-driven hospital operations and care orchestration platform that helps health systems reduce manual work and surface clinical risks earlier. Closely parallels Datlowe's value proposition of automating surveillance and freeing clinical staff time.
- Qventus: US-based AI platform that provides real-time operational and clinical decision support for hospitals, including automated surveillance and risk detection. Highly comparable to Datlowe's HAIDI/MERIE model of continuously analyzing hospital data to surface actionable clinical insights.
- Artisight: Hospital-focused AI platform combining computer vision and sensor data for patient safety, infection control, and operational efficiency. Directly comparable in the AI-powered hospital surveillance and risk-detection category.
- First Databank (FDB): Medication clinical decision support vendor providing drug-interaction and dosing databases embedded in hospital EHRs. Direct comparable to Datlowe's MERIE application for pharmacotherapy risk monitoring.
- AKASA: AI platform automating healthcare operations including clinical workflows and revenue cycle for hospitals and health systems. Comparable AI-native enterprise model targeting hospital automation and manual-workload reduction.
- Notable: AI platform automating hospital workflows including clinical documentation, coding, and patient outreach. Comparable as a workflow-automation AI vendor targeting enterprise hospitals to reduce manual administrative burden.
Broad incumbents
- Dedalus: Large European healthcare IT vendor offering EHR, diagnostic, and care-coordination solutions across multiple EU countries. A relevant broad incumbent because it competes for the same hospital IT budgets and increasingly embeds AI surveillance features.
- Wolters Kluwer Health: Global clinical decision support vendor (UpToDate, Medi-Span, Sentri7) widely embedded in hospital EHRs for medication safety and infection surveillance. Comparable broad incumbent competing in Datlowe's clinical decision support space.
- CompuGroup Medical: Leading European provider of EHR and health-IT software serving hospitals, physicians, and pharmacies across CEE and DACH. Competes with Datlowe's hospital customer base for clinical decision support budgets and could acquire or replicate Datlowe-style AI.
Emerging players
- Infermedica: Polish-founded AI health company offering symptom-checking, triage, and clinical decision support APIs. Comparable as a CEE-origin health-AI vendor with hospital/payer customers, though focused on pre-diagnostic triage rather than in-hospital surveillance.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Datlowe social profiles
Digital presenceDatlowe compliance and trust
Trust signalCompliance2 records
Datlowe financial estimates
Financial estimateRevenue estimate
Valuation estimate
Datlowe leadership team
Management profileNumber of profiles
Profiles5 records
Datlowe funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Datlowe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Datlowe
What does Datlowe do?
Datlowe develops and sells an AI-powered healthcare data analytics platform deployed on-premise inside hospitals. Its two flagship applications, HAIDI for real-time hospital infection surveillance and MERIE for real-time pharmacotherapy monitoring, continuously analyze clinical data (clinical notes, lab results, prescriptions, patient records) to detect risks earlier than traditional manual surveillance methods and generate actionable alerts for healthcare professionals.
Is Datlowe a public or private company?
Datlowe is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Datlowe founded?
Datlowe was founded in 2017. It employs 1 to 10 people.
Where is Datlowe based?
Datlowe is headquartered in Malá Strana, Czechia, in the Europe region.
How does Datlowe make money?
Two revenue lines are on record. AI Platform Subscription (HAIDI) is the primary driver. The others are AI Platform Subscription (MERIE).
Who are Datlowe's main competitors?
Direct peers on record are LeanTaas, Qventus, Artisight, First Databank (FDB), AKASA and Notable. Broad incumbents are Dedalus, Wolters Kluwer Health and CompuGroup Medical. Infermedica is listed as an emerging player.
Does Datlowe have an API?
No public API is recorded for Datlowe.
What industry is Datlowe in?
Datlowe's product category is Healthcare AI Analytics Software. Its primary akta.pro industry code is HLACANAE, SaMD – Monitoring, Triage & Risk Stratification Software, with a secondary code of HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms. Its NAICS code is 541513 and its SIC code is 8000.